# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-26-001593
Filing Date
2026-03-23
Accepted
2026-03-23 16:07:51
Documents
97
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | zk2634510.htm iXBRL | 20-F | 2244572
2 | EXHIBIT 12.1 | exhibit_12-1.htm | EX-12.1 | 14098
3 | EXHIBIT 12.2 | exhibit_12-2.htm | EX-12.2 | 14476
4 | EXHIBIT 13.1 | exhibit_13-1.htm | EX-13.1 | 4508
5 | EXHIBIT 13.2 | exhibit_13-2.htm | EX-13.2 | 4470
6 | EXHIBIT 15.1 | exhibit_15-1.htm | EX-15.1 | 2734
7 | GRAPHIC | image00001.jpg | GRAPHIC | 2739
8 | GRAPHIC | image0.jpg | GRAPHIC | 271504
9 | GRAPHIC | image1.jpg | GRAPHIC | 489851
10 | GRAPHIC | image2.jpg | GRAPHIC | 712101
11 | GRAPHIC | image3.jpg | GRAPHIC | 309712
12 | GRAPHIC | image4.jpg | GRAPHIC | 920426
13 | GRAPHIC | image5.jpg | GRAPHIC | 521953
14 | GRAPHIC | image6.jpg | GRAPHIC | 577473
15 | GRAPHIC | image7.jpg | GRAPHIC | 681420
16 | GRAPHIC | image8.jpg | GRAPHIC | 230039
17 | GRAPHIC | image9.jpg | GRAPHIC | 543388
18 | GRAPHIC | image10.jpg | GRAPHIC | 289564
19 | GRAPHIC | image11.jpg | GRAPHIC | 613014
20 | GRAPHIC | image13.jpg | GRAPHIC | 982505
21 | GRAPHIC | image14.jpg | GRAPHIC | 688030
22 | GRAPHIC | image16.jpg | GRAPHIC | 1060809
23 | GRAPHIC | image17.jpg | GRAPHIC | 467332
24 | GRAPHIC | image18.jpg | GRAPHIC | 466287
25 | GRAPHIC | image19.jpg | GRAPHIC | 188553
| Complete submission text file | 0001178913-26-001593.txt |  | 35259276

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
26 | XBRL SCHEMA FILE | cmmb-20251231.xsd | EX-101.SCH | 65552
27 | XBRL CALCULATION FILE | cmmb-20251231_cal.xml | EX-101.CAL | 47325
28 | XBRL DEFINITION FILE | cmmb-20251231_def.xml | EX-101.DEF | 171992
29 | XBRL LABEL FILE | cmmb-20251231_lab.xml | EX-101.LAB | 636921
30 | XBRL PRESENTATION FILE | cmmb-20251231_pre.xml | EX-101.PRE | 310650
101 | EXTRACTED XBRL INSTANCE DOCUMENT | zk2634510_htm.xml | XML | 1248866

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV Israel
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV Israel 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38807 | Film No.: 26782266
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)